| abstract |
The present invention provides tyrosine kinase inhibitors, in particular Bruton's tyrosine kinase ("BTK") inhibitors, and is therefore useful for the treatment of diseases such as cancer, autoimmune, inflammatory and thromboembolic diseases. A compound that inhibits a disease treated by BTK. The invention also provides pharmaceutical compositions containing such compounds and methods for preparing such compounds. |